Experimental Drug Yields Dramatic Weight Loss – The New York Times
Experimental Drug Yields Dramatic Weight Loss – The New York Times
An experimental shot helped participants in a large trial lose far more weight than obesity drugs already on the market, Eli Lilly, the maker, announced on Thursday.
Among the heaviest patients in the trial, the results were on par with those seen with gastric bypass surgery, the only effective treatment for most with severe obesity.
The drug, retatrutide, appears to be the most powerful yet in a wave of injections and pills that have transformed the treatment of obesity — so much so that some participants in other research have said they stopped taking retatrutide because they felt they were losing too much weight.
If the drug’s effects do not wane with time, and if its results in the real world echo those in the clinical trial, it may extend the notion of what a weight loss drug can accomplish.